Orphan Therapeutics Accelerator In-Licenses Gene Therapy for Rare Pediatric OTC Deficiency

OTXL-101, a promising therapy in development for a severe, rare pediatric metabolic condition, becomes the first pipeline program to be in-licensed by Or...

October 29, 2026 | Thursday | News
SEKISUI Diagnostics Launches 510(k)-Cleared COVID-19 and Flu A&B Combo Test

SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&...

October 29, 2026 | Thursday | News
CellsBin Wins NCI SBIR Award to Advance Blood-Based Multiple Myeloma Test

CellsBin®, a biotechnology company pioneering Rare-Cell Biology™, announced that it has received a Direct-to-Phase II Small Business Innov...

October 29, 2026 | Thursday | News
Astellas Secures Option to License Audax’s DAX-044 Immuno-Oncology Candidate in US$285m Deal

Astellas Pharma Inc. [TSE: 4503, President and CEO: Naoki Okamura, "Astellas"] and Audax Biosciences Pty Ltd ("Audax")  announced that they have ent...

October 29, 2026 | Thursday | News
Abbott Launches Next-Generation Oncodetect MRD Test Using Whole-Genome Sequencing

Powered by whole-genome sequencing and MAESTRO* technology, the next-generation Oncodetect test takes a distinct approach to MRD,...

October 28, 2026 | Wednesday | News
OSE Immunotherapeutics Reports Positive Phase 2 Results for Tedopi in Metastatic Lung Cancer

Topline results to be presented by Federico Cappuzzo, MD, PhD, on October 25, 2026, at the Annual Meeting of the European Society for Medical Oncology (E...

October 20, 2026 | Tuesday | News
Cardurion Reports Positive Phase 2 Results for Tovinontrine in HFrEF

In Cycle-1REF Phase 2 clinical trial, tovinontrine demonstrated substantial reduction in NT-proBNP, a biomarker for heart failure, in patients with HFrEF o...

October 13, 2026 | Tuesday | News
Everest Medicines Strengthens mRNA Team with Two Former Moderna Executives

Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & ...

October 12, 2026 | Monday | News
Neurosterix Completes Phase 1 Study of NTX-253 for Schizophrenia

Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allos...

October 09, 2026 | Friday | News
Lakewood-Amedex Reports Positive Preclinical Data for Bisphosphocin Antimicrobials

Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting,...

October 08, 2026 | Thursday | News
Lundbeck Reports Phase Ib Results for Lu AF28996 in Advanced Parkinson’s Disease

Results from an 18-week, open-label Phase Ib trial of investigational Lu AF28996 in people with advanced Parkinson's disease are being presented at MDS 2...

October 07, 2026 | Wednesday | News
Beactica Therapeutics Selects BEA-28 as Preclinical Candidate for Solid Tumours

Beactica Therapeutics AB, a Swedish precision medicine company, announced the selection of BEA-28 as a preclinical candidate for its TEAD programme, which ...

October 07, 2026 | Wednesday | News
AAVantgarde Reports Updated Gene Therapy Data for Usher Syndrome and Stargardt Disease

AAVantgarde Bio (AAVantgarde), the clinical-stage biotechnology company developing genetic medicines for inherited retinal diseases (IRDs) using its propri...

October 06, 2026 | Tuesday | News
InSilicoTrials Joins ARPA-H CIRCLE Project to Advance Digital Twins for Critical Illness

InSilicoTrials, a cloud-based platform for AI and computational modeling and simulation in healthcare, today announced that it is a subawardee on a team ...

September 28, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close